Loading stock dataβ¦
β¬22.30+0.08 (+0.36%)
Koninklijke Philips N.V.
Koninklijke Philips N.V. in the Healthcare sector is trading at β¬22.30 with a market capitalization of $22.8B. Wall Street consensus targets β¬26.84 (20 analysts), implying a +20.4% move over the next 12 months. The stock is currently 19% below its 52-week high of β¬27.70, remaining 3.9% below its 200-day moving average. The Whystock Score of 45/100 suggests a balanced risk-reward profile.
| Metric (EUR) | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Total Revenue | β¬4.34Bβ | β¬4.30Bβ | β¬5.10Bβ | β¬3.90Bβ | β¬4.36B |
| Gross Profit | β¬2.01Bβ | β¬1.91Bβ | β¬2.29Bβ | β¬1.77Bβ | β¬2.15B |
| Operating Income | β¬401.00Mβ | β¬330.00Mβ | β¬565.00Mβ | β¬242.00Mβ | β¬610.00M |
| Net Income | β¬240.00Mβ | β¬184.00Mβ | β¬395.00Mβ | β¬151.00Mβ | β¬384.00M |
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imagin...